tag:blogger.com,1999:blog-36634196.post5650713297290866541..comments2023-10-09T11:33:37.853-05:00Comments on The IN VIVO Blog: Betting on the Saxagliptin Advisory CommitteeChris Morrisonhttp://www.blogger.com/profile/04075266444951558159noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-36634196.post-72746444725777438072009-04-03T12:50:00.000-05:002009-04-03T12:50:00.000-05:00The DPP IV combos both Galvus and Januvia have bee...The DPP IV combos both Galvus and Januvia have been disappointing. It will be interesting to see Onglyza combo. <BR/><BR/>The rumor is Saxagliptin and Metformin XR combo, being developed by its partner is very promising. <BR/><BR/>The recent FDA guidance for diabetic drug approval has heightened the regulatory barrier for new class of drugs so much that such product extension makes sense. <BR/><BR/>Jo StaurtJo Staurtnoreply@blogger.com